Redox Factor-1 Inhibits Cyclooxygenase-2 Expression via Inhibiting of p38 MAPK in the A549 Cells.

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Dae Goon YooByeong Hwa Jeon

Abstract

In this study, we evaluated the role of apurinic/apyrimidinic endonuclease1/redox factor-1 (Ref-1) on the tumor necrosis factor-alpha (TNF-alpha) induced cyclooxygenase-2 (COX-2) expression using A549 lung adenocarcinoma cells. TNF-alpha induced the expression of COX-2 in A549 cells, but did not induce BEAS-2B expression. The expression of COX-2 in A549 cells was TNF-alpha dose-dependent (5~100 ng/ml). TNF-alpha-stimulated A549 cells evidenced increased Ref-1 expression in a dose-dependent manner. The adenoviral transfection of cells with AdRef-1 inhibited TNF-alpha-induced COX-2 expression relative to that seen in the control cells (Adbetagal). Pretreatment with 10 microM of SB203580 suppressed TNF-alpha-induced COX-2 expression, thereby suggesting that p38 MAPK might be involved in COX-2 expression in A549 cells. The phosphorylation of p38 MAPK was increased significantly after 5 minutes of treatment with TNF-alpha, reaching a maximum level at 10 min which persisted for up to 60 min. However, p38MAPK phosphorylation was markedly suppressed in the Ref-1-overexpressed A549 cells. Taken together, our results appear to indicate that Ref-1 negatively regulates COX-2 expression in response to cytokine stimulation via the inhibition...Continue Reading

References

Feb 5, 2000·Carcinogenesis·M T Yip-SchneiderC J Sweeney
Oct 6, 2000·Mutation Research·A R EvansM R Kelley
Nov 22, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Y HosomiA Ochiai
Apr 26, 2001·The Journal of Biological Chemistry·M DohadwalaS M Dubinett
Aug 22, 2001·Trends in Cell Biology·V Baud, M Karin
Mar 14, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H Y FangL-S Wang
Apr 3, 2003·Nature Reviews. Cancer·S Perwez HussainCurtis C Harris
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N K AltorkiA J Dannenberg
Oct 8, 2003·The Annals of Thoracic Surgery·J Esteban CastelaoRoss M Bremner
Feb 12, 2005·Antioxidants & Redox Signaling·Gianluca TellMark R Kelley
Dec 6, 2005·Cardiovascular Research·Cuk Seong KimByeong Hwa Jeon
Dec 27, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·ShouWei Han, Jesse Roman
Oct 3, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Philippe Dje N'GuessanStefan Hippenstiel
Sep 19, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Duygu DerinErkan Topuz
Dec 7, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Dae Goon YooByeong Hwa Jeon
Oct 11, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eleftherios DalaverisKonstantinos Kostikas
Oct 23, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hye-Mi LeeEun-Kyeong Jo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.